论文信息 - Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial - 字舞流文

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

H. Serve | A. Wolf | P. Bader | O. Ottmann | S. Metzelder | S. Huenecke | G. Bug | A. Burchert | E. Wagner | N. Kroeger | Saskia Gueller | S. Gueller | Z. Jedličková | Stephan Metzelder